Cargando…

The mechanism and clinical application of DNA damage repair inhibitors combined with immune checkpoint inhibitors in the treatment of urologic cancer

Urologic cancers such as kidney, bladder, prostate, and uroepithelial cancers have recently become a considerable global health burden, and the response to immunotherapy is limited due to immune escape and immune resistance. Therefore, it is crucial to find appropriate and effective combination ther...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Deqian, Jiang, Bowen, Wang, Shijin, Wang, Qifei, Wu, Guangzhen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248030/ https://www.ncbi.nlm.nih.gov/pubmed/37305685 http://dx.doi.org/10.3389/fcell.2023.1200466

Ejemplares similares

A Novel DNA Repair Gene Signature for Immune Checkpoint Inhibitor-Based Therapy in Gastric Cancer
por: Yuan, Binbin, et al.
Publicado: (2022)

Myt1 overexpression mediates resistance to cell cycle and DNA damage checkpoint kinase inhibitors
por: Sokhi, Sargun, et al.
Publicado: (2023)

Regulatory roles of ferroptosis-related non-coding RNAs and their research progress in urological malignancies
por: Wang, Shijin, et al.
Publicado: (2023)

DNA Damage Response and Repair in Adaptive Immunity
por: Luo, Sha, et al.
Publicado: (2022)

DNA damage checkpoint execution and the rules of its disengagement
por: Yam, Candice Qiu Xia, et al.
Publicado: (2022)

Blocking DNA Damage Repair May Be Involved in Stattic (STAT3 Inhibitor)-Induced FLT3-ITD AML Cell Apoptosis
por: Luo, Yuxuan, et al.
Publicado: (2021)

The Half-Life-Extended IL21 can Be Combined With Multiple Checkpoint Inhibitors for Tumor Immunotherapy
por: Wu, Shaoxian, et al.
Publicado: (2021)

Targeting Cancer Cell Ferroptosis to Reverse Immune Checkpoint Inhibitor Therapy Resistance
por: Deng, Jingjing, et al.
Publicado: (2022)

Crosstalk Between the Tumor Microenvironment and Cancer Cells: A Promising Predictive Biomarker for Immune Checkpoint Inhibitors
por: Li, Xiaoying, et al.
Publicado: (2021)

Editorial: DNA damage and repair in reproductive and embryo cells
por: Rocco, Lucia, et al.
Publicado: (2023)

DNA damage and repair: underlying mechanisms leading to microcephaly
por: Ribeiro, Jessica Honorato, et al.
Publicado: (2023)

Targeting Tumor-Associated Macrophages as a Potential Strategy to Enhance the Response to Immune Checkpoint Inhibitors
por: Cassetta, Luca, et al.
Publicado: (2018)

Predictive Value of Max’s Giant Associated Protein Mutation in Outcomes of Lung Adenocarcinoma Patients Treated With Immune Checkpoint Inhibitors
por: Qu, Yan, et al.
Publicado: (2021)

Identification of an Immune-Related LncRNA Signature in Gastric Cancer to Predict Survival and Response to Immune Checkpoint Inhibitors
por: Ding, Zuoyou, et al.
Publicado: (2021)

A Systematic Review of the Mechanisms Involved in Immune Checkpoint Inhibitors Cardiotoxicity and Challenges to Improve Clinical Safety
por: Rubio-Infante, Nestor, et al.
Publicado: (2022)

A Genomic Signature Reflecting Fibroblast Infiltration Into Gastric Cancer Is Associated With Prognosis and Treatment Outcomes of Immune Checkpoint Inhibitors
por: Lu, Yi, et al.
Publicado: (2022)

A Ferroptosis-Related Gene Prognostic Index to Predict Temozolomide Sensitivity and Immune Checkpoint Inhibitor Response for Glioma
por: Cai, Yonghua, et al.
Publicado: (2022)

The Effect of Smoking on the Immune Microenvironment and Immunogenicity and Its Relationship With the Prognosis of Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer
por: Sun, Yueqin, et al.
Publicado: (2021)

Tumor Suppressor FBXW7 and Its Regulation of DNA Damage Response and Repair
por: Lan, Huiyin, et al.
Publicado: (2021)

PBX1 Attenuates Hair Follicle-Derived Mesenchymal Stem Cell Senescence and Apoptosis by Alleviating Reactive Oxygen Species-Mediated DNA Damage Instead of Enhancing DNA Damage Repair
por: Wang, Yuan, et al.
Publicado: (2021)

DNA Damage Repair Deficiency in Pancreatic Ductal Adenocarcinoma: Preclinical Models and Clinical Perspectives
por: Stoof, Jojanneke, et al.
Publicado: (2021)

The Capacity to Repair Sperm DNA Damage in Zygotes is Enhanced by Inhibiting WIP1 Activity
por: Leem, Jiyeon, et al.
Publicado: (2022)

BRAF Mutation as a Potential Therapeutic Target for Checkpoint Inhibitors: A Comprehensive Analysis of Immune Microenvironment in BRAF Mutated Colon Cancer
por: Cen, Shuyi, et al.
Publicado: (2021)

Increased WIP1 Expression With Aging Suppresses the Capacity of Oocytes to Respond to and Repair DNA Damage
por: Leem, Jiyeon, et al.
Publicado: (2021)

Molecular and Clinical Significance of Stanniocalcin-1 Expression in Breast Cancer Through Promotion of Homologous Recombination-Mediated DNA Damage Repair
por: Hou, Jing, et al.
Publicado: (2021)

PARP1 Inhibitor Combined With Oxaliplatin Efficiently Suppresses Oxaliplatin Resistance in Gastric Cancer-Derived Organoids via Homologous Recombination and the Base Excision Repair Pathway
por: Li, Huafu, et al.
Publicado: (2021)

Collateral Victim or Rescue Worker?—The Role of Histone Methyltransferases in DNA Damage Repair and Their Targeting for Therapeutic Opportunities in Cancer
por: He, Lishu, et al.
Publicado: (2021)

Role of Base Excision Repair Pathway in the Processing of Complex DNA Damage Generated by Oxidative Stress and Anticancer Drugs
por: Baiken, Yeldar, et al.
Publicado: (2021)

Functions of the CSB Protein at Topoisomerase 2 Inhibitors-Induced DNA Lesions
por: Busatto, Franciele Faccio, et al.
Publicado: (2021)

Multi-Omics Analysis of the Anti-tumor Synergistic Mechanism and Potential Application of Immune Checkpoint Blockade Combined With Lenvatinib
por: Lu, Yuting, et al.
Publicado: (2021)

Role of microRNA carried by small extracellular vesicles in urological tumors
por: Mao, Yiping, et al.
Publicado: (2023)

Advances in early detection methods for solid tumors
por: Jiang, Bowen, et al.
Publicado: (2023)

Research progress in inducing immunogenic cell death of tumor cells
por: Xie, Deqian, et al.
Publicado: (2022)

The Mitochondrial Response to DNA Damage
por: Rong, Ziye, et al.
Publicado: (2021)

Lysine Methyltransferase Inhibitors Impair H4K20me2 and 53BP1 Foci in Response to DNA Damage in Sarcomas, a Synthetic Lethality Strategy
por: Campillo-Marcos, Ignacio, et al.
Publicado: (2021)

Let’s not take DNA breaks for granted. The importance of direct detection of DNA breaks for the successful development of DDR inhibitors
por: Solarczyk, Kamil, et al.
Publicado: (2023)

Long Non-coding RNA Aerrie Controls DNA Damage Repair via YBX1 to Maintain Endothelial Cell Function
por: Pham, Tan Phát, et al.
Publicado: (2021)

Nucleic Acid Sensing Pathways in DNA Repair Targeted Cancer Therapy
por: Xie, Bingteng, et al.
Publicado: (2022)

Olaparib, a PARP-1 inhibitor, protects retinal cells from ocular hypertension-associated oxidative damage
por: Yang, Yuting, et al.
Publicado: (2022)

The ATM-E6AP-MASTL axis mediates DNA damage checkpoint recovery
por: Li, Yanqiu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o576mf9vfsedup0sti7rm12e0s